Sally Roberts

Summary

Country: New Zealand

Publications

  1. ncbi Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003
    Sally A Roberts
    Department of Microbiology, LabPlus, Auckland District Health Board, Auckland, New Zealand
    J Antimicrob Chemother 57:992-8. 2006
  2. doi Comparison of the MGIT TBc immunochromatographic assay with the Accuprobe Gen-Probe TB assay for identification of Mycobacterium tuberculosis complex: results from a low-burden tuberculosis setting
    Sally A Roberts
    Mycobacteria Section, Department of Microbiology, Auckland District Health Board, Auckland New Zealand
    Diagn Microbiol Infect Dis 74:415-6. 2012
  3. ncbi Implementing and sustaining a hand hygiene culture change programme at Auckland District Health Board
    Sally A Roberts
    Department of Microbiology, LabPlus, Auckland City Hospital, Park Road, Grafton, Auckland, New Zealand
    N Z Med J 125:75-85. 2012
  4. ncbi Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009
    Sally Roberts
    Department of Microbiology, LabPlus, Auckland District Health Board, Grafton, Auckland, New Zealand
    N Z Med J 124:45-51. 2011
  5. ncbi Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue
    S Roberts
    Department of Microbiology, LabPlus, Auckland District Health Board, Auckland, New Zealand
    Intern Med J 35:S97-105. 2005
  6. ncbi Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand
    Sushil Pandey
    Department of Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand
    Pathology 41:582-4. 2009
  7. ncbi Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy
    Deborah A Williamson
    Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    J Antimicrob Chemother 68:2898-906. 2013
  8. ncbi A reservoir for methicillin-resistant Staphylococcus aureus in the Auckland community?
    Simon Briggs
    Department of Microbiology, Auckland District Health Board
    N Z Med J 115:U182. 2002
  9. ncbi Vancomycin-resistant enterococcal colonisation of hospitalised patients in Auckland
    Simon Briggs
    Auckland Hospital, Grafton, Auckland, New Zealand
    N Z Med J 115:U145. 2002
  10. doi Clinical parameters do not predict infection in patients with external ventricular drains: a retrospective observational study of daily cerebrospinal fluid analysis
    Sharmini Muttaiyah
    Department of Microbiology, Auckland City Hospital, Auckland, New Zealand
    J Med Microbiol 57:207-9. 2008

Collaborators

Detail Information

Publications24

  1. ncbi Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003
    Sally A Roberts
    Department of Microbiology, LabPlus, Auckland District Health Board, Auckland, New Zealand
    J Antimicrob Chemother 57:992-8. 2006
    ..This study reports the national trend of antibiotic susceptibility of clinically significant anaerobes in New Zealand...
  2. doi Comparison of the MGIT TBc immunochromatographic assay with the Accuprobe Gen-Probe TB assay for identification of Mycobacterium tuberculosis complex: results from a low-burden tuberculosis setting
    Sally A Roberts
    Mycobacteria Section, Department of Microbiology, Auckland District Health Board, Auckland New Zealand
    Diagn Microbiol Infect Dis 74:415-6. 2012
    ..The BD TBc Antigen assay was more sensitive than and as specific as the Gen-Probe TB assay, making it a useful alternative for the rapid detection of MTB...
  3. ncbi Implementing and sustaining a hand hygiene culture change programme at Auckland District Health Board
    Sally A Roberts
    Department of Microbiology, LabPlus, Auckland City Hospital, Park Road, Grafton, Auckland, New Zealand
    N Z Med J 125:75-85. 2012
    ..We describe the implementation process and assess the effectiveness of this programme 36 months after implementation...
  4. ncbi Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009
    Sally Roberts
    Department of Microbiology, LabPlus, Auckland District Health Board, Grafton, Auckland, New Zealand
    N Z Med J 124:45-51. 2011
    ..The aim of this study was to provide baseline information on the molecular epidemiology and the antimicrobial susceptibility of Clostridium difficile (C. difficile) clinical isolates from patients throughout New Zealand...
  5. ncbi Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue
    S Roberts
    Department of Microbiology, LabPlus, Auckland District Health Board, Auckland, New Zealand
    Intern Med J 35:S97-105. 2005
    ..Although a number of the newer antibiotics such as linezolid and quinopristin/dalfopristin have been shown to have good activity against MRSA, these agents should only be used with specialist advice...
  6. ncbi Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand
    Sushil Pandey
    Department of Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand
    Pathology 41:582-4. 2009
    ....
  7. ncbi Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy
    Deborah A Williamson
    Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    J Antimicrob Chemother 68:2898-906. 2013
    ..coli bacteraemia by comparing the phylogenetic, resistance and virulence characteristics of post-TRUS biopsy E. coli bloodstream isolates with E. coli bloodstream isolates from male patients with spontaneous urosepsis...
  8. ncbi A reservoir for methicillin-resistant Staphylococcus aureus in the Auckland community?
    Simon Briggs
    Department of Microbiology, Auckland District Health Board
    N Z Med J 115:U182. 2002
    ....
  9. ncbi Vancomycin-resistant enterococcal colonisation of hospitalised patients in Auckland
    Simon Briggs
    Auckland Hospital, Grafton, Auckland, New Zealand
    N Z Med J 115:U145. 2002
    ..To assess the prevalence of vancomycin-resistant enterococcal colonisation of hospitalised patients in five selected Auckland hospitals...
  10. doi Clinical parameters do not predict infection in patients with external ventricular drains: a retrospective observational study of daily cerebrospinal fluid analysis
    Sharmini Muttaiyah
    Department of Microbiology, Auckland City Hospital, Auckland, New Zealand
    J Med Microbiol 57:207-9. 2008
    ..Gram-negative isolates were less frequently isolated, but, when present, were always associated with ventriculitis. This study found that patient temperature and GCS did not allow early prediction of EVD-associated ventriculitis...
  11. ncbi Excess cost associated with Staphylococcus aureus poststernotomy mediastinitis
    Arlo Upton
    Department of Clinical Microbiology, Auckland District Health Board, Auckland, New Zealand
    N Z Med J 118:U1316. 2005
    ..To determine the additional cost attributable to Staphylococcus aureus poststernotomy mediastinitis (PSM) following sternotomy for cardiac surgery at Green Lane Hospital...
  12. doi The characteristics of intramucosal bacteria in chronic rhinosinusitis: a prospective cross-sectional analysis
    Raymond Kim
    Department of Surgery, The University of Auckland, Auckland, New Zealand
    Int Forum Allergy Rhinol 3:349-54. 2013
    ..We sought to determine whether the tissue colonies had genotypic or phenotypic variations from the surface bacteria...
  13. ncbi The Auckland City Hospital Device Point Prevalence Survey 2005: utilisation and infectious complications of intravascular and urinary devices
    Stephen Ritchie
    Auckland City Hospital, Auckland
    N Z Med J 120:U2683. 2007
    ....
  14. ncbi The excess cost associated with healthcare-associated bloodstream infections at Auckland City Hospital
    Andrew Burns
    Department of Microbiology, Auckland District Health Board, Auckland, New Zealand
    N Z Med J 123:17-24. 2010
    ..This study was undertaken to determine the cost of healthcare-associated bloodstream infections (HA-BSI) in adult patients admitted to an Auckland City Hospital...
  15. pmc Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand
    Atheer Safar
    Auckland City Hospital, Auckland, New Zealand
    Emerg Infect Dis 17:983-9. 2011
    ..Seventy-four percent of patients who died had an underlying condition. To the population in our study, the proposed 26-valent vaccine would provide limited benefit...
  16. ncbi Infective endocarditis in new zealand children 1994-2012
    Rachel Webb
    From the Department of Pediatric Infectious Diseases, Starship Children s Hospital, Auckland Department of Microbiology, Auckland District Health Board Department of Pediatric and Congenital Cardiac Services, Starship Children s Hospital, Auckland and School of Population Child and Youth Health, University of Auckland, Auckland, New Zealand
    Pediatr Infect Dis J 33:437-42. 2014
    ..We sought to describe the clinical and microbiology features of children with infective endocarditis (IE) between 1994 and 2012...
  17. ncbi Haemophilus influenzae type b disease in Auckland children during the Hib vaccination era: 1995-2009
    Bonnie Leung
    University of Auckland
    N Z Med J 125:21-9. 2012
    ..To characterise Haemophilus influenzae type b (Hib) invasive disease in the era of Hib vaccination, in children of the greater Auckland region of New Zealand...
  18. ncbi Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults
    Rod Ellis-Pegler
    Department of Infectious Diseases, Auckland Hospital, Auckland, New Zealand
    Clin Infect Dis 37:658-62. 2003
    ..Three days of intravenous benzyl penicillin is sufficient treatment for adults with meningococcal disease. The usual recommendations for duration of treatment are excessive...
  19. ncbi Corynebacterium species isolated from patients with mastitis
    Sue Paviour
    Microbiology Laboratory, LabPlus, Auckland Hospital, Auckland, New Zealand
    Clin Infect Dis 35:1434-40. 2002
    ....
  20. doi Cannabis, ischemic stroke, and transient ischemic attack: a case-control study
    Peter Alan Barber
    Department of Neurology, Auckland City Hospital, Auckland, New Zealand
    Stroke 44:2327-9. 2013
    ..There is a temporal relationship between cannabis use and stroke in case series and population-based studies...
  21. doi Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand: additional justification for assumption of age-determined immunity based on local data
    Deborah Williamson
    Departments of Virology and Immunology, LabPlus, Auckland City Hospital, Auckland, New Zealand
    Infect Control Hosp Epidemiol 31:1082-4. 2010
    ..Some studies suggest that age-specific immunity cannot be assumed. In our local setting, however, we found that 893 (98%) of 912 healthcare workers more than 40 years old tested seropositive for measles immunoglobulin G...
  22. ncbi Pilot fatigue in short-haul operations: effects of number of sectors, duty length, and time of day
    David M C Powell
    Medical Unit, Air New Zealand, Auckland, New Zealand
    Aviat Space Environ Med 78:698-701. 2007
    ..There is little research on what factors are associated with fatigue in short-haul pilots. The aim was to investigate how length of duty, number of sectors, time of day, and departure airport affect fatigue levels in short-haul operations...
  23. pmc Candida infective endocarditis
    J W Baddley
    Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294 0006, USA
    Eur J Clin Microbiol Infect Dis 27:519-29. 2008
    ..Indications for surgical intervention are different and mortality is increased. Newer antifungal treatment options are increasingly used. Large, multi-center studies are needed to help better define Candida IE...
  24. ncbi Should we be doing endoscope surveillance cultures?
    Richard Everts
    N Z Med J 115:U101. 2002